Hot Topics in Immunization

Activity Preview

This review will describe recent changes in recommended immunization practices, including the introduction of new vaccines, and will explore other immunization issues of interest to pharmacists. This activity will also discuss several recent changes that have occurred in immunization practices in the United States, including approval of a 9-valent human papilloma virus vaccine and a meningococcal B vaccine; changes to recommendations for pneumococcal vaccinations and the use of influenza vaccine in patients with egg allergy; and new recommendationsfor the use of vaccines by patients taking immunosuppressive medications. In addition, pharmacists should be familiar with recommendations for pertussis vaccination to combat the ongoing pertussis epidemic. 



Learning Objectives

After participating in this activity, the pharmacist will be able to:

  1. Provide recommendations on the use of vaccines to prevent human papilloma virus.
  2. Determine when patients should be vaccinated against tetanus, diphtheria, and/or pertussis, and select an appropriate vaccine.
  3. Provide recommendations on the use of pneumococcal vaccines, and determine the appropriate vaccines and timing for individual patients.
  4. Describe the appropriate use of meningococcal B vaccine.
  5. Discuss recommendations on the use of influenza vaccine in patients with a history of egg allergy.
  6. Use recommendations from the Infectious Diseases Society of America to determine which vaccinations are appropriate for patients with medication-induced immunosuppression. 

Activity type: Knowledge-based
Learning Level: 2


Accreditation Information

ACPE logo

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

To obtain 2.0 contact hours of continuing pharmacy education credit (0.2 CEUs) for completing "Hot Topics in Immunization," complete the CPE examination and evaluation questions. Credit will be awarded upon achieving a passing grade of 70% or better. Please visit CPE Monitor for your statement of credit/transcript.

APhA continuing pharmacy education policy provides you with two opportunities to successfully complete this continuing pharmacy education examination. Please note that you will not be permitted to submit the examination a third time. Exam questions may not appear in the same order as printed.

The current policy of the APhA Education Department is not to release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the test. Individuals completing this activity by May 1, 2019 can receive credit.

Initial release date: May 1, 2016
Expiration date: May 1, 2019
ACPE Universal Activity Number: 0202-0000-16-109-H04-P


Advisory Board

Stephen L. Foster, PharmD, FAPhA,
Professor, University of Tennessee College of Pharmacy,
Liaison Representative to Advisory Committee on Immunization Practices, CDC
CAPT (Ret), U.S. Public Health Service.
Memphis, Tennessee 



Stephen L. Foster, PharmD, FAPhA, declares that he is on the speakers bureaus for Merck Vaccines, Sanofi Pasteur, and Pfizer, and on the advisory boards for Pfizer and Seqirus. APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete staff disclosures, please see the APhA Accreditation Information section at



"Hot Topics in Immunization” is a home-study continuing education activity for pharmacists developed by the American Pharmacists Association.


Activity Fee

There is no fee associated with this activity for members of the American Pharmacists Association. There is a $25 fee for nonmembers.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-16-109-H04-P 0.2 CEUs May 01, 2016 - May 01, 2019